President and CEO
Dr. Flaim holds a doctorate in Human Physiology and Pharmacology from the University of California at Davis. He held faculty positions in Medicine and Physiology at the Pennsylvania State University College of Medicine and senior management roles at the Johnson & Johnson Pharmaceutical Research Institute, the Squibb Institute for Medical Research, Alliance Pharmaceutical Corporation, Trega Biosciences, Inc. and Galileo Pharmaceuticals, Inc. Dr. Flaim is a Fellow of the American College of Cardiology, the American Heart Association, the American College of Clinical Pharmacology, and the Royal Society of Medicine. He is a board member of Pivotal Biosciences, Inc., CardioCreate, Inc. and Chairman of the Board of OncoFluor, Inc. Dr. Flaim is Chair Emeritus of the Board of Governors for the Tech Coast Angels, Past President and Chair Emeritus of the San Diego Network of Tech Coast Angels and board member of the Angel Capital Association. He is a member of the Editorial Board of the Journal of Pharmacology and Experimental Therapeutics, founding member of the Board of Directors for the John G. Watson Foundation and is active in numerous regional and national scientific organizations. He is a Technology and Business advisor to the William J. von Liebig Center for Entrepreneurism and Technology Advancement at the University of California, San Diego, and Senior Special Advisor & Investor-in-Residence to the Office of Translational Alliances and Coordination in the Division of Extramural Research Activities at the National Heart, Lung and Blood Institutes of the National Institutes of Health.